alpha-Linolenic Acid

interleukin 6 ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35563819 Alpha-Linolenic Acid Modulates T Cell Incorporation in a 3D Tissue-Engineered Psoriatic Skin Model. 2022 Apr 30 2
2 31245005 Individual free fatty acids have unique associations with inflammatory biomarkers, insulin resistance and insulin secretion in healthy and gestational diabetic pregnant women. 2019 1
3 29107850 Inflammatory markers in dependence on the plasma concentration of 37 fatty acids after the coronary stent implantation. 2018 Feb 5 1
4 29698923 Anti-inflammatory effects of α-linolenic acid in M1-like macrophages are associated with enhanced production of oxylipins from α-linolenic and linoleic acid. 2018 Jul 1
5 26912161 α-Linolenic acid increases the G0/G1 switch gene 2 mRNA expression in peripheral blood mononuclear cells from obese patients: a pilot study. 2016 Feb 24 1
6 20463041 High habitual dietary alpha-linolenic acid intake is associated with decreased plasma soluble interleukin-6 receptor concentrations in male twins. 2010 Jul 2
7 19234585 Alpha-linolenic acid supplementation and resistance training in older adults. 2009 Feb 4
8 19723085 Inhibitory mechanism of omega-3 fatty acids in pancreatic inflammation and apoptosis. 2009 Aug 2
9 17284733 Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. 2007 Feb 2
10 15678256 Apolipoprotein E genotype in dyslipidemic patients and response of blood lipids and inflammatory markers to alpha-linolenic Acid. 2005 Jan-Feb 1
11 16169525 Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. 2005 Oct 28 1
12 15226473 Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. 2004 Jul 1
13 12818406 Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. 2003 Apr 3
14 10416955 Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. 1999 May 1